Jing-En Li

Dr. Jing-En Li

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
JLJing-En Li
Jing-En Li
WWWen-Jun Wang
Wen-Jun Wang
GZGuo-Dong Zheng
Guo-Dong Zheng
LLLin-Yan Li
Lin-Yan Li

1 October 2013 in International Immunopharmacology
Verified
Journal Article
Closed access
JLJing-En Li
Jing-En Li
SNShao-Ping Nie
Shao-Ping Nie
MXMing-Yong Xie
Ming-Yong Xie
DHDan-Fei Huang
Dan-Fei Huang
YWYu-Ting Wang
Yu-Ting Wang
CLChang Li
Chang Li

24 February 2024 in Phytomedicine
Verified
Journal Article
Closed access
WZWenkai Zhang
Wenkai Zhang
LYLonghui Yu
Longhui Yu
QYQinru Yang
Qinru Yang
JZJinfeng Zhang
Jinfeng Zhang
WWWenjing Wang
Wenjing Wang
GZGuodong Zheng
Guodong Zheng

31 August 2021 in Molecules
Verified
Journal Article
Open access
PDF file
BSBeiyun Shen
Beiyun Shen
XSXinchen Shangguan
Xinchen Shangguan
ZYZhongping Yin
Zhongping Yin
SWShaofu Wu
Shaofu Wu
QZQing-Feng Zhang
Qing-Feng Zhang
JCJiguang Chen
Jiguang Chen
The inhibition of α-glucosidase is a clinical strategy for the treatment of type 2 diabetes mellitus (T2DM), and many natural plant ingredients have been reported to be effective in alleviating hyperglycemia by inhibiting α-glucosidase. In this study, the α-glucosidase inhibitory activity of fisetin extracted from Cotinus coggygria Scop. was evaluated in vitro. The results showed that fisetin exhibited strong inhibitory activity with an IC50 value of 4.099 × 10−4 mM. Enzyme kinetic analysis revealed that fisetin is a non-competitive inhibitor of α-glucosidase, with an inhibition constant value of 0.01065 ± 0.003255 mM. Moreover, fluorescence spectrometric measurements indicated the presence of only one binding site between fisetin and α-glucosidase, with a binding constant (lgKa) of 5.896 L·mol−1. Further molecular docking studies were performed to evaluate the interaction of fisetin with several residues close to the inactive site of α-glucosidase. These studies showed that the structure of the complex was maintained by Pi-Sigma and Pi-Pi stacked interactions. These findings illustrate that fisetin extracted from Cotinus coggygria Scop. is a promising therapeutic agent for the treatment of T2DM.

30 November 2022 in Food & Function
Verified
Journal Article
Closed access
PDF file
QDQihuan Deng
Qihuan Deng
WWWenjun Wang
Wenjun Wang
LZLieyuan Zhang
Lieyuan Zhang
LCLingli Chen
Lingli Chen
QZQing-Feng Zhang
Qing-Feng Zhang
JLJing-En Li
Jing-En Li
Many natural polysaccharides have been proven to have ameliorative effects on high-fat diet-induced hyperlipidemia with fewer side effects. However, similar data on Gougunao tea polysaccharides remain obscure. In this study, we aimed to investigate the role of Gougunao tea polysaccharides (GTP40) in the alleviation of hyperlipidemia and regulation of gut microbiota in C57BL/6J mice induced by a high-fat diet. The results indicated that GTP40 intervention inhibited the abnormal growth of body weight and the excessive accumulation of lipid droplets in the livers and ameliorated the biochemical parameters of serum/liver related to lipid metabolism in hyperlipidemia mice. The elevated levels of antioxidant enzyme and anti-inflammation cytokine in serum, as well as the up-regulating anti-inflammation gene in the liver, reflected that GTP40 might mitigate the oxidative and inflammatory stress induced by a high-fat diet. In addition, GTP40 could modulate the composition, abundance, and diversity of gut microbiota in hyperlipidemia mice. Besides, Spearman's correlation analysis implied that GTP40 intervention could enrich beneficial bacteria (e.g., Akkermansia, Bacteroides, Roseburia, and Alistipes), and decrease harmful bacteria (e.g., Blautia, Faecalibaculum, Streptococcus, and norank_f_Desulfovibrionaceae), which were correlated with the lipid metabolic parameters associated with hyperlipidemia. Moreover, it also indicated that there was a significant correlation between gut microbiota and SCFAs. Thus, GTP40 may be a novel strategy against fat accumulation, oxidative stress, and inflammation, as well as restoring the normal microbial balance of the gut in hyperlipidemia mice.

6 May 2024 in Current Research in Food Science
Verified
Journal Article
Open access
JDJinjiao Dong
Jinjiao Dong
WWWenjun Wang
Wenjun Wang
GZGuodong Zheng
Guodong Zheng
NWNansheng Wu
Nansheng Wu
JXJingjing Xie
Jingjing Xie
JLJing-En Li
Jing-En Li
Choerospondias axillaris fruit has attracted more and more attention due to its various pharmacological activities, which are rich in polysaccharides. This study investigated the in vitro saliva-gastrointestinal digestion and fecal fermentation behaviors of polysaccharides from Choerospondias axillaris fruit (CAP), as well as its impact on human gut microbiota. The results showed that CAP could be partially degraded during the gastrointestinal digestion. The FT-IR spectra of the digested CAP didn't change significantly, however, the morphological feature of SEM changed to disordered flocculent and rod-like structures. 16S rRNA sequencing analysis found that after in vitro fermentation, CAP could increase the relative abundances of beneficial bacteria including Megasphaera, Megamonas and Bifidobacterium to produce short-chain fatty acids (SCFAs), while it can also reduce the abundances of harmful bacteria of Collinsella, Gemmiger, Klebsiella and Citrobacter, suggesting that CAP could modulate the composition and abundance of gut microbiota. These results implied that CAP can be developed as a potential prebiotic in the future.